| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. | President & Chief Executive Officer, Director | Stock Option (right to buy) | 340,000 | 19 Jan 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | 19 Jan 2022 | 1 | $0 | 4 | President & Chief Executive Officer, Director | 21 Jan 2022, 15:15 |
| FULC | Fulcrum Therapeutics, Inc. | 10 Aug 2021 | 6 | -$754,600 | 4 | President & Chief Executive Officer, Director | 12 Aug 2021, 16:20 |